ATROPINE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Atropine (autoinjector) patents expire, and when can generic versions of Atropine (autoinjector) launch?
Atropine (autoinjector) is a drug marketed by Rafa Labs Ltd and is included in one NDA.
The generic ingredient in ATROPINE (AUTOINJECTOR) is atropine. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATROPINE (AUTOINJECTOR)?
- What are the global sales for ATROPINE (AUTOINJECTOR)?
- What is Average Wholesale Price for ATROPINE (AUTOINJECTOR)?
Summary for ATROPINE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | ATROPINE (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "ATROPINE (AUTOINJECTOR) drug patent expirations")
Recent Clinical Trials for ATROPINE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| U.S. Army Space and Missile Defense Command | Phase 1 |
| MicroDose Defense Products L.L.C. | Phase 1 |
| University of Pittsburgh | Phase 1 |
Pharmacology for ATROPINE (AUTOINJECTOR)
| Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
US Patents and Regulatory Information for ATROPINE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rafa Labs Ltd | ATROPINE (AUTOINJECTOR) | atropine | SOLUTION;INTRAMUSCULAR | 212319-001 | Jul 9, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
